Erratum: Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid (Chemical Research in Toxicology (2014) 27:5 (775?786) DOI: 10.1021/tx400451q);Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid

Chemical Research in Toxicology

Volumn 27, Issue 5, 2014, Pages 775-786

  Xiong, Aizhen ^a,d   Yang, Fan ^a   Fang, Lianxiang ^a   Yang, Li ^a   He, Yuqi ^b   Wan, Yvonne Yu Jui ^b   Xu, Ying ^a   Qi, Meng ^a   Wang, Xiuli ^c   Yu, Kate ^c   Tsim, Karl Wah Keung ^d   Wang, Zhengtao ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WATERS CORPORATION   (United States)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450; GLYCINE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; SENECIONINE; SODIUM BILE ACID COTRANSPORTER; TAURINE; MESSENGER RNA; PYRROLIZIDINE ALKALOID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID METABOLISM; CONTROLLED STUDY; GENOMICS; HISTOPATHOLOGY; LIQUID CHROMATOGRAPHY; LIVER TOXICITY; MALE; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BLOOD; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; BILE ACIDS AND SALTS; GENE EXPRESSION REGULATION; GENOMICS; LIVER; MALE; METABOLOMICS; PYRROLIZIDINE ALKALOIDS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84901024381     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx500270p     Document Type: Erratum

References (71)

1. Roeder, E. (1995) Medicinal plants in Europe containing pyrrolizidine alkaloids Pharmazie 50, 83-98
2. Roeder, E. (2000) Medicinal plants in China containing pyrrolizidine alkaloids Pharmazie 55, 711-726
3. Wiedenfeld, H. and Edgar, J. (2011) Toxicity of pyrrolizidine alkaloids to humans and ruminants Phytochem. Rev. 10, 137-151
4. International Programme on Chemical Safety (1988) Pyrrolizidine Alkaloids, Environmental Health Criteria 80, WHO, Geneva, Switzerland.
5. Fu, P. P., Xia, Q. S., Lin, G., and Chou, M. W. (2004) Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms Drug Metabo. Rev. 36, 1-55 (Pubitemid 38387834)
6. Chojkier, M. (2003) Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids J. Hepatol. 39, 437-446 (Pubitemid 37070264)
7. Altaee, M. Y. and Mahmood, M. H. (1998) An outbreak of veno-occlusive disease of the liver in northern Iraq East. Mediterr. Health J. 4, 142-148 (Pubitemid 128471037)
8. Dai, N., Yu, Y. C., Ren, T. H., Wu, J. G., Jiang, Y., Shen, L. G., and Zhang, J. (2007) Gynura root induces hepatic veno-occlusive disease: A case report and review of the literature World J. Gastroenterol. 13, 1628-1631 (Pubitemid 46672677)
9. Kakar, F., Akbarian, Z., Leslie, T., Mustafa, M. L., Watson, J., Egmond, H. P. E., Omar, M. F., and Mofleh, J. (2010) An outbreak of hepatic veno-occlusive disease in western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids J. Toxicol. 1-7
10. Bane, A., Seboxa, T., Mesfin, G., Ali, A., Tsegaye, Y., Tensae, M., Selassie, S., and Haile, T. (2012) An outbreak of veno-occlusive liver disease in northern Ethiopia, clinical findings Ethiop. Med. J. 50 (Suppl) 9-16
11. Helmy, A. (2006) Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome Aliment. Pharmacol. Ther. 23, 11-25 (Pubitemid 43381162)
12. Wadleigh, M., Ho, V., Momtaz, P., and Richardson, P. (2003) Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment Curr. Opinion Fematol. 10, 451-462 (Pubitemid 37352490)
13. Lewis, C. J. (2001) Safety Alerts and Advisors: FDA Advises Dietary Supplement Manufacturers to Remove Comfrey Products from the Market, 2001, U.S. Food and Drug Administration Web site. http://www.fda.gov/Food/ RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm111219.htm (accessed Jul 6, 2001).
14. State Pharmacopoeia Commission of the P. R. China (2010) Pharmacopoeia of the People's Republic of China, China Medicinal Science and Technology Press, Beijing, China.
15. International Programme on Chemical Safety (1989) Pyrrolizidine Alkaloids Health and Safety Guide, Health and Safety Guide No. 26, WHO, Geneva, Switzerland.
16. Lin, G., Wang, J. Y., Li, N., Li, M., Gao, H., Ji, Y., Zhang, F., Wang, H. L., Zhou, Y., Ye, Y., Xu, H. X., and Zheng, J. (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum J. Hepatol. 54, 666-673
17. Lin, G., Cui, Y. Y., Liu, X. Q., and Wang, Z. T. (2002) Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine Chem. Res. Toxicol. 15, 1421-1428 (Pubitemid 35364904)
18. Kim, H. Y., Stermitz, F. R., and Coulombe, R. A. (1995) Pyrrolizidine alkaloid-induced DNA-protein cross-links Carcinogenesis 16, 2691-2697
19. Kim, H. Y., Stermitz, F. R., Li, J. K., and Coulombe, R. (1999) Comparative DNA cross-linking by activated pyrrolizidine alkaloids Food Chem. Toxicol. 37, 619-625 (Pubitemid 29438562)
20. Chou, M. W., Jian, Y., Williams, L. D., Xia, Q., Churchwell, M., Doerge, D. R., and Fu, P. P. (2003) Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid, in vitro and in vivo Chem. Res. Toxicol. 16, 1130-1137 (Pubitemid 37163219)
21. Zhao, Y., Xia, Q., Gamboa da Costa, G., Yu, H., Cai, L., and Fu, P. P. (2012) Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation Chem. Res. Toxicol. 25, 1985-1996
22. Ji, L. L., Chen, Y., Liu, T. Y., and Wang, Z. T. (2008) Involvement of Bcl-xL degradation and mitochondrial-mediated apoptotic pathway in pyrrolizidine alkaloids-induced apoptosis in hepatocytes Toxicol. Appl. Pharmacol. 231, 393-400
23. Liu, T. Y., Wang, Z. Y., Ji, L. L., and Wang, Z. T. (2010) Pyrrolizidine alkaloid isoline induced oxidative injury in various mouse tissues Exp. Toxicol. Pathol. 62, 251-257
24. Chen, Y., Ji, L. L., Xiong, A. Z., Yang, L., and Wang, Z. T. (2013) Involvement of intracellular glutathione in regulating isoline-induced cytotoxicity in human normal liver L-02 cells Toxicol. Ind. Health 29, 567-575
25. Wang, Z. Y., Kang, H., Ji, L. L., Yang, Y. Q., Liu, T. Y., Cao, Z. W., Morahan, G., and Wang, Z. T. (2012) Proteomic characterization of the possible molecular targets of pyrrolizidine alkaloid isoline-induced hepatotoxicity Environ. Toxicol. Pharmacol. 34, 608-617
26. Nicholson, J. K., Connelly, J., Lindon, J. C., and Holmes, E. (2002) Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug Discovery 1, 153-161 (Pubitemid 41646523)
27. Lindon, J. C., Nicholson, J. K., Holmes, E., Antti, H., Bollard, M. E., Keun, H., Beckonert, O., Ebbels, T. M., Reily, M. D., Robertson, D., Stevens, G. J., Luke, P., Breau, A. P., Cantor, G. H., Bible, R. H., Niederhauser, U., Senn, H., Schlotterbeck, G., Sidelmann, U. G., Laursen, S. M., Tymiak, A., Car, B. D., Lehman-McKeeman, L., Colet, J. M., Loukaci, A., and Thomas, C. (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project Toxicol. Appl. Pharmacol. 187, 137-146 (Pubitemid 36349345)
28. Zhang, A. H., Sun, H., Qiu, S., and Wang, X. J. (2013) NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis Magn. Reson. Chem. 51, 549-556
29. Beyoglu, D. and Idle, J. R. (2013) The metabolomic window into hepatobiliary disease J. Hepatol. 59, 842-858
30. Jiang, J., Nilsson-Ehle, P., and Xu, N. (2006) Influence of liver cancer on lipid and lipoprotein metabolism Lipids Health Dis. 5, 4-10
31. Miyoshi, H., Moriya, K., Tsutsumi, T., Shinzawa, S., Fujie, H., Shintani, Y., Fujinaga, H., Goto, K., Todoroki, T., Suzuki, T., Miyamura, T., Matsuura, Y., Yotsuyanagi, H., and Koike, K. (2011) Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein J. Hepatol. 54, 432-438
32. Holecek, M., Mraz, J., and Tilser, I. (1996) Plasma amino acids in four models of experimental liver injury in rats Amino Acids 10, 229-241 (Pubitemid 26159931)
33. Wu, G. Y. (2009) Amino acids: metabolism, functions, and nutrition Amino Acids 37, 1-17
34. Xu, Y., Yang, L., Yang, F., Xiong, Y. H., and Wang, Z. T. (2012) Metabolic profiling of fifteen amino acids in serum of chemical-induced liver injured rats by hydrophilic interaction liquid chromatograph coupled with tandem mass spectrometry Metabolomics 8, 475-483
35. 4 - and α-naphthylisothiocyanate- induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography- mass spectrometry Chem. Res. Toxicol. 21, 2280-2288
36. 4 -induced acute liver injury: An ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic spproach for the pharmacodynamic study of traditional Chinese medicines (TCMs) Int. J. Mol. Sci. 13, 14634-14647
37. Yang, F., Xu, Y., Xiong, A. Z., He, Y. Q., Yang, L., Wan, Y-J.Y., and Wang, Z. T. (2012) Evaluation of the protective effect of Rhei Radix et Rhizoma against α-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acids J. Ethnopharmacol. 144, 599-604
38. Chen, J., Deng, W., Wang, J., Shao, Y., Ou, M., and Ding, M. (2013) Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy Int. J. Gynaecol. Obstet. 1, 5-8
39. Lake, A. D., Novak, P., Shipkova, P., Aranibar, N., Robertson, D., Reily, M. D., Lu, Z., Lehman-McKeeman, L. D., and Cherrington, N. J. (2013) Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease Toxicol. Appl. Pharmacol. 2, 132-140
40. Lessard, P., Wilson, W. D., Olander, H. J., Rogers, Q. R., and Mendel, V. E. (1986) Clinicopathologic study of horses surviving pyrrolizidine alkaloid (Senecio vulgaris) toxicosis Am. J. Vet. Res. 47, 1776-1780 (Pubitemid 16032010)
41. Mendel, V. E., Witt, M. R., Gitchell, B. S., Gribble, D. N., Rogers, Q. R., Segall, H. J., and Knight, H. D. (1988) Pyrrolizidine alkaloid-induced liver disease in horses: an early diagnosis Am. J. Vet. Res. 49, 572-578
42. Sutherland, R. J., Deol, H. S., and Hood, P. J. (1992) Changes in plasma bile acids, plasma amino acids, and hepatic enzyme pools as indices of functional impairment in liver-damaged sheep Vet. Clin. Pathol. 21, 51-56
43. Yan, C. C. and Huxtable, R. J. (1995) Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver Toxicol. Appl. Pharmacol. 130, 132-139
44. Liang, Q. N., Sheng, Y., Jiang, P., Ji, L. L., Xia, Y., Min, Y., and Wang, Z. T. (2011) The gender-dependent difference of liver GSH antioxidant system in mice and its influence on isoline-induced liver injury Toxicology 280, 61-69
45. Griffin, D. S. and Segall, H. J. (1987) Lipid peroxidation and cellular damage caused by the pyrrolizidine alkaloid senecionine, the alkenal trans-4-hydroxy-2-hexenal, and related alkenals Cell Biol. Toxicol. 3, 379-390
46. Griffin, D. S. and Segall, H. J. (1987) Role of cellular calcium homeostasis in toxic liver injury induced by the pyrrolizidine alkaloid senecionine and the alkenal trans-4-OH- 2-hexenal J. Biochem. Toxicol. 2, 155-167
47. E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients J. Proteome. Res. 9, 2377-2389
48. Van den Berg, R. A., Hoefsloot, H. C., Westerhuis, J. A., Smilde, A. K., and van der Werf, M. J. (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics 7, 142-156
49. Xiong, A. Z., Yang, L., Ji, L. L., Wang, Z. Y., Yang, X. J., Chen, Y., Wang, X. L., Wang, C. H., and Wang, Z. T. (2012) UPLC-MS based metabolomics study on two Senecio herbs, Senecio scandens and S. vulgaris: an approach for the differentiation of genetically closed species with similar morphology but different toxicity Metabolomics 8, 614-623
50. Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J., Edlund, U., Shockcor, J. P., Gottfries, J., Moritz, T., and Trygg, J. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models Anal. Chem. 80, 115-122 (Pubitemid 351448411)
51. Xie, G. X., Ni, Y., Su, M. M., Zhang, Y. Y., Zhao, A. H., Gao, X. F., Liu, Z., Xiao, P. G., and Jia, W. (2008) Application of ultra-performance LC-TOF MS metabolite profiling techniques to the analysis of medicinal Panax herbs Metabolomics 4, 248-260
52. Yin, P. Y., Wan, D. F., Zhao, C. Z., Chen, J., Zhao, X. J., Wang, W. Z., Lu, X., Yang, S. L., Gu, J. R., and Xu, G. W. (2009) A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol. Biosyst. 5, 868-876
53. Bittel, D. C., Kibiryeva, N., and Butler, M. G. (2007) Whole genome microarray analysis of gene expression in subjects with fragile X syndrome Genet. Med. 9, 464-472 (Pubitemid 47222139)
54. Li, Y., Wang, H., Yang, B., Yang, J., Ruan, X., Yang, Y., Wakeland, E. K., Li, Q., and Fang, X. (2012) Influence of carbon monoxide on growth and apoptosis of human umbilical artery smooth muscle cells and vein endothelial cells Int. J. Biol. Sci. 8, 1431-1446
55. Boulesteix, A. L. and Strimmer, K. (2006) Partial least squares: A versatile tool for the analysis of high dimensional genomic data Briefing Bioinf. 8, 32-44
56. Trygg, J. and Wold, S. (2002) Orthogonal projections to latent structures (O-PLS) J. Chemom. 16, 119-128
57. DeLeve, L. D., McCuskey, R. S., Wang, X., Hu, L., McCuskey, M. K., Epstein, R. B., and Kanel, G. C. (1999) Characterization of a reproducible rat model of hepatic veno-occlusive disease Hepatology 29, 1779-1791 (Pubitemid 29247052)
58. Morita, M., Ishida, N., Uchiyama, K., Yamaguchi, K., Itoh, Y., Shichiri, M., Yoshida, Y., Hagihara, Y., Naito, Y., Yoshikawa, T., and Niki, E. (2012) Fatty liver induced by free radicals and lipid peroxidation Free Radical Res. 46, 758-765
59. Niki, E. (2014) Biomarkers of lipid peroxidation in clinical material Biochim. Biophys. Acta 1840, 809-817
60. Claudel, R., Steals, B., and Kuipers, F. (2005) The farnesoid X receptor: A molecular link between bile acid and lipid and glucose metabolism Arterioscler., Thromb., Vasc. Biol. 25, 2020-2030
61. Calkin, A. C. and Tontonoz, P. (2012) Transcriptional integration of metabolism by the nuclear sterolactivated receptors LXR and FXR Nat. Rev. Mol. Cell Biol. 13, 213-224
62. Nicolaou, M., Andress, E. J., Zolnerciks, J. K., Dixon, P. H., Williamson, C., and Linton, K. J. (2012) Canalicular ABC transporters and liver disease J. Pathol. 226, 300-315
63. Wu, X. P., Chai, J., and Chen, W. S. (2009) Changes of cholesterol 7alpha-hydroxylase, farnesoid X receptor, and heterodimer partner expression in liver tissues of rats with obstructive cholestasis Acad. J. Sec. Mil. Med. Univ. 30, 1398-1401
64. Abu-Hayyeh, S., Papacleovoulou, G., Lovgren-Sandblom, A., Tahir, M., Oduwole, O., Jamaludin, N. A., Ravat, S., Nikolova, V., Chambers, J., Selden, C., Rees, M., Marschall, H. U., Parker, M. G., and Williamson, C. (2013) Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit FXR resulting in a pro-cholestatic phenotype Hepatology 57, 716-726
65. Yang, F., Huang, X. F., Yi, T. S., Yen, Y., Moore, D. D., and Huang, W. D. (2007) Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor Cancer Res. 67, 863-867
66. Zollner, G., Fickert, P., Zenz, R., Fuchsbichler, A., Stumptner, C., Kenner, L., Ferenci, P., Stauber, R. E., Krejs, G. J., Denk, H., Zatloukal, K., and Trauner, M. (2004) Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases Hepatology 33, 633-646 (Pubitemid 32185226)
67. Geier, A., Dietrich, C. G., Gerloff, T., Haendly, J., Kullak-Ublick, G. A., Stieger, B., Meier, P. J., Matern, S., and Gartung, C. (2003) Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat Biochim. Biophys. Acta 1609, 87-94 (Pubitemid 36044069)
68. Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., and Meier, P. J. (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver Gastroenterology 118, 422-430 (Pubitemid 30067515)
69. Cao, J., Huang, L., Liu, Y., Hoffman, T., Stieger, B., Meier, P. J., and Vore, M. (2001) Rregulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin Hepatology 33, 140-147 (Pubitemid 32016896)
70. Soroka, C. J., Lee, J. M., Azzaroli, F., and Boyer, J. L. (2001) Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver Hepatology 33, 783-791 (Pubitemid 32246625)
71. Teng, S. and Piquette-Miller, M. (2007) Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis Br. J. Pharmacol. 151, 367-376 (Pubitemid 46842676)